Literature DB >> 9215135

Biopsy diagnosis of prostatic cancer--current areas of concern.

M R Feneley, M C Parkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9215135      PMCID： PMC499868          DOI： 10.1136/jcp.50.4.265

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  19 in total

1.  Exploration of new pathologic factors in terms of potential for prognostic significance and future applications.

Authors:  A C von Eschenbach; M K Brawer; P A di Sant'Agnese; P A Humphrey; H Mahran; G P Murphy; T J Sebo; R Veltri
Journal:  Cancer       Date:  1996-07-15       Impact factor: 6.860

2.  Patterns of progression in prostate cancer.

Authors:  J E McNeal; D G Bostwick; R A Kindrachuk; E A Redwine; F S Freiha; T A Stamey
Journal:  Lancet       Date:  1986-01-11       Impact factor: 79.321

3.  Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies.

Authors:  D G Bostwick
Journal:  Am J Surg Pathol       Date:  1994-08       Impact factor: 6.394

4.  The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis.

Authors:  M R Cupp; D G Bostwick; R P Myers; J E Oesterling
Journal:  J Urol       Date:  1995-05       Impact factor: 7.450

5.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

Authors:  J I Epstein; P C Walsh; M Carmichael; C B Brendler
Journal:  JAMA       Date:  1994-02-02       Impact factor: 56.272

6.  Standardized in vitro mapping with multiple core biopsies of total prostatectomy specimens: localization and prediction of tumour volume and grade.

Authors:  M Häggman; O Nybacka; B Nordin; C Busch
Journal:  Br J Urol       Date:  1994-11

7.  Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

Authors:  William J Catalona; Jerome P Richie; Frederick R Ahmann; M'Liss A Hudson; Peter T Scardino; Robert C Flanigan; Jean B DeKernion; Timothy L Ratliff; Louis R Kavoussi; Bruce L Dalkin; W Bedford Waters; Michael T MacFarlane; Paula C Southwick
Journal:  J Urol       Date:  1994-05       Impact factor: 7.450

8.  The Bristol prostate cancer pilot screening study--a 3-year follow-up.

Authors:  S F Brewster; T Kemple; A G MacIver; J P Astley; J C Gingell
Journal:  Br J Urol       Date:  1994-11

9.  Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies.

Authors:  M K Terris; D J Haney; I M Johnstone; J E McNeal; T A Stamey
Journal:  Urology       Date:  1995-01       Impact factor: 2.649

10.  Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens.

Authors:  P A Peller; D C Young; D P Marmaduke; W L Marsh; R A Badalament
Journal:  Cancer       Date:  1995-01-15       Impact factor: 6.860
View more
  1 in total

1.  Does screening for prostate cancer identify clinically important disease?

Authors:  M R Feneley
Journal:  Ann R Coll Surg Engl       Date:  1999-05       Impact factor: 1.891
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.